Immunotherapy for pediatric AML
0 विचारों
• 07/04/23
0
0
एम्बेड
administrator
ग्राहकों
Sarah Tasian, MD, Children's Hospital of Philadelphia, Philadelphia, PA, outlines the current immunotherapeutic landscape with a focus on ongoing clinical trials for pediatric patients with acute myeloid leukemia (AML). Specifically, bispecific T-cell-engaging antibodies, natural killer (NK) cells and CAR-T cells are discussed. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां